Your browser doesn't support javascript.
loading
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali, Sandro; Pizzamiglio, Sara; Touati, Nathan; Litiere, Saskia; Marreaud, Sandrine; Kasper, Bernd; Gelderblom, Hans; Stacchiotti, Silvia; Judson, Ian; Dei Tos, Angelo P; Verderio, Paolo; Casali, Paolo G; Woll, Penella J; Gronchi, Alessandro.
Affiliation
  • Pasquali S; Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. Electronic address: sandro.pasquali@istitutotumori.mi.it.
  • Pizzamiglio S; Unit of Bioinformatics and Biostatistics, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Touati N; European Organisation for Research and Treatment of Cancer (EORTC), Belgium.
  • Litiere S; European Organisation for Research and Treatment of Cancer (EORTC), Belgium.
  • Marreaud S; European Organisation for Research and Treatment of Cancer (EORTC), Belgium.
  • Kasper B; University of Heidelberg, Mannheim University Medical Center, Interdisciplinary Tumor Center, Sarcoma Unit, Mannheim, Germany.
  • Gelderblom H; Department of Clinical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.
  • Stacchiotti S; Medical Oncology Unit 2, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Judson I; The Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Dei Tos AP; Treviso General Hospital, Treviso, Italy; Department of Medicine, University of Padova, Padova, Italy.
  • Verderio P; Unit of Bioinformatics and Biostatistics, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Casali PG; Medical Oncology Unit 2, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy; The Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, United Kingdom; Treviso General Hospital, Treviso, Italy; Department of Medicine, University of Padova,
  • Woll PJ; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK.
  • Gronchi A; Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. Electronic address: alesssandro.gronchi@istitutotumori.mi.it.
Eur J Cancer ; 109: 51-60, 2019 03.
Article de En | MEDLINE | ID: mdl-30690293
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sarcomes / Protocoles de polychimiothérapie antinéoplasique / Traitement médicamenteux adjuvant / Traitement néoadjuvant / Nomogrammes / Membres / Tronc Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Eur J Cancer Année: 2019 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sarcomes / Protocoles de polychimiothérapie antinéoplasique / Traitement médicamenteux adjuvant / Traitement néoadjuvant / Nomogrammes / Membres / Tronc Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Eur J Cancer Année: 2019 Type de document: Article